Abstract
AbstractCompound (I), an analogue of the clinically tested calcitonin gene‐related peptide receptor antagonist MK‐3207, is identified as a CGRP receptor antagonist with suitable potency, selectivity, and pharmacokinetics to interrogate the in vivo effects of receptor blockade.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
